Cyanidin induces apoptosis and differentiation in prostate cancer cells

International Journal of Oncology

Volumn 47, Issue 4, 2015, Pages 1303-1310

  Sorrenti, Valeria ^a   Vanella, Luca ^a   Acquaviva, Rosaria ^a   Cardile, Venera ^a   Giofrè, Salvatore ^b   Di Giacomo, Claudia ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Apoptosis; Cyanidin; Cytodifferentiation; Prostate cancer

Indexed keywords

ANTHOCYANIN; CASPASE 3; CELL DNA; CYANIDIN 3 O BETA GLUCOPYRANOSIDE; GLUTATHIONE; LACTATE DEHYDROGENASE; PROTEIN P21; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CYANIDIN-3-O-BETA-GLUCOPYRANOSIDE;

ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLOGY; DNA FRAGMENTATION; DRUG EFFECT; DRUG SENSITIVITY; DU145 CELL LINE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LNCAP CELL LINE; MALE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; CELL DIFFERENTIATION; CELL SURVIVAL; COMET ASSAY; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ANTHOCYANINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; COMET ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84941004227     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3130     Document Type: Article

References (46)

1. Ferlay J, Parkin DM and Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781, 2010.
2. American Cancer Society: Prostate Cancer Statistics 2013. http://www.cancer.org. Accessed May 20, 2013.
3. American Society of Clinical Oncology Prostate Cancer Statistics: http://www.cancer.net/prostate. Accessed May 20, 2013.
4. Ito K: Prostate cancer in Asian men. Nat Rev Urol 11: 197-212, 2014.
5. Arnold JT and Isaacs JT: Mechanisms involved in the progression of androgen-independent prostate cancers: It is not only the cancer cell's fault. Endocr Relat Cancer 9: 61-73, 2002.
6. Chen J and Xu X: Diet, epigenetic, and cancer prevention. Adv Genet 71: 237-255, 2010.
7. Kang NJ, Shin SH, Lee HJ and Lee KW: Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol Ther 130: 310-324, 2011.
8. Weng CJ and Yen GC: Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38: 76-87, 2012.
9. Russo A, Piovano M, Lombardo L, Vanella L, Cardile V and Garbarino J: Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells. Anticancer Drugs 17: 1163-1169, 2006.
10. Yim D, Singh RP, Agarwal C, Lee S, Chi H and Agarwal R: A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res 65: 1035-1044, 2005.
11. Cardile V, Scifo C, Russo A, Falsaperla M, Morgia G, Motta M, Renis M, Imbriani E and Silvestre G: Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer. Anticancer Res 23C: 4921-4926, 2003.
12. Russo A, Berretta M, Cardile V, Lombardo L, Vanella L, Troncoso N, Garbarino J, Ignazio B and Li Volti G: Pharmacological induction of heme oxygenase-1 reduces KB cell viability: Role of carbon monoxide. J Carcinog & Mutagen 2014, http://dx.doi.org/10.4172/2157-2518.S8-009. Accessed April 16, 2014.
13. Waxman S: Differentiation therapy in acute myelogenous leukemia (non-APL). Leukemia14: 491-496, 2000.
14. Vanella L, Barbagallo I, Acquaviva R, Di Giacomo C, Cardile V, Abraham NG and Sorrenti V: Ellagic acid: Cytodifferentiating and antiproliferative effects in human prostatic cancer cell lines. Curr Pharm Des 19: 2728-2736, 2013.
15. Breitman T, Collins SJ and Keene B: Terminal differentiation of human promyelocytic leukemic cells in promyelocytic leukemic cells in primary culture response to retinoic acid. Blood 57: 1000-1004, 1981.
16. Ohno R, Asou N and Ohnishi K: Treatment of acute promyelocytic leukemia: Strategy toward further increase of cure rate. Leukemia 17: 1454-1463, 2003.
17. Vanella L, Di Giacomo C, Acquaviva R, Barbagallo I, Cardile V, Kim DH, Abraham NG and Sorrenti V: Apoptotic markers in a prostate cancer cell line: Effect of ellagic acid. Oncol Rep 30: 2804-2810, 2013.
18. Vanella L, Di Giacomo C, Acquaviva R, Barbagallo I, Li Volti G, Cardile V, Abraham NG and Sorrenti V: Effects of ellagic Acid on angiogenic factors in prostate cancer cells. Cancers (Basel) 5: 726-738, 2013.
19. Wang H, Race EJ and Shrikhande AJ: Characterization of anthocyanins in grape juices by ion trap liquid chromatography-mass spectrometry. J Agric Food Chem 51: 1839-1844, 2003.
20. Seeram NP, Cichewicz RH, Chandra A and Nair MG: Cyclooxygenase inhibitory and antioxidant compounds from crabapple fruits. J Agric Food Chem 51: 1948-1951, 2003.
21. Amorini AM, Fazzina G, Lazzarino G, Tavazzi B, Di Pierro D, Santucci R, Sinibaldi F, Galvano F and Galvano G: Activity and mechanism of the antioxidant properties of cyanidin-3-O-betaglucopyranoside. Free Radic Res 35: 953-966, 2001.
22. Lee HS: Characterization of major anthocyanins and the color of red-fleshed Budd Blood orange (Citrus sinensis). J Agric Food Chem 50: 1243-1246, 2002.
23. Matsumoto H, Inaba H, Kishi M, Tominaga S, Hirayama M and Tsuda T: Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agric Food Chem 49: 1546-1551, 2001.
24. Tsuda T, Horio F and Osawa T: Absorption and metabolism of cyanidin 3-O-beta-D-glucoside in rats. FEBS Lett 449: 179-182, 1999.
25. Ichikawa H, Ichiyanagi T, Xu B, Yoshii Y, Nakajima M and Konishi T: Antioxidant activity of anthocyanin extract from purple black rice. J Med Food 4: 211-218, 2001.
26. Khkönen MP and Heinonen M: Antioxidant activity of anthocyanins and their aglycons. J Agric Food Chem 51: 628-633, 2003.
27. Briviba K, Abrahamse SL, Pool-Zobel BL and Rechkemmer G: Neurotensin-and EGF-induced metabolic activation of colon carcinoma cells is diminished by dietary flavonoid cyanidin but not by its glycosides. Nutr Cancer 41: 172-179, 2001.
28. Hagiwara A, Miyashita K, Nakanishi T, Sano M, Tamano S, Kadota T, Koda T, Nakamura M, Imaida K, Ito N, et al: Pronounced inhibition by a natural anthocyanin, purple corn color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in male F344 rats pretreated with 1,2-dimethylhydrazine. Cancer Lett 171: 17-25, 2001.
29. Fimognari C, Berti F, Nüsse M, Cantelli-Forti G and Hrelia P: Induction of apoptosis in two human leukemia cell lines as well as differentiation in human promyelocytic cells by cyanidin-3-O-beta-glucopyranoside. Biochem Pharmacol 67: 2047-2056, 2004.
30. Serafino A, Sinibaldi-Vallebona P, Lazzarino G, Tavazzi B, Rasi G, Pierimarchi P, Andreola F, Moroni G, Galvano G, Galvano F, et al: Differentiation of human melanoma cells induced by cyanidin-3-O-β-glucopyranoside. FASEB J 18: 1940-1942, 2004.
31. Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, Marinari UM and Domenicotti C: Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013: 972913, 2013.
32. Vanella L, Di Giacomo C, Acquaviva R, Santangelo R, Cardile V, Barbagallo I, Abraham NG and Sorrenti V: The DDAH/NOS pathway in human prostatic cancer cell lines: Antiangiogenic effect of L-NAME. Int J Oncol 39: 1303-1310, 2011.
33. Sigala S, Tognazzi N, Rizzetti MC, Faraoni I, Missale C, Bonmassar E and Spano P: Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145. Eur J Endocrinol 147: 407-415, 2002.
34. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
35. Acquaviva R, Di Giacomo C, Sorrenti V, Galvano F, Santangelo R, Cardile V, Gangia S, D'Orazio N, Abraham NG and Vanella L: Antiproliferative effect of oleuropein in prostate cell lines. Int J Oncol 41: 31-38, 2012.
36. Romeo R, Giofr SV, Garozzo A, Bisignano B, Corsaro A and Chiacchio MA: Synthesis and biological evaluation of furopyrimidine N,O-nucleosides. Bioorg Med Chem 21: 5688-5693, 2013.
37. Romeo R, Giofr SV, Carnovale C, Campisi A, Parenti R, Bandini L and Chiacchio MA: Synthesis and biological evaluation of 3-hydroxymethyl-5-(1H-1,2,3-triazol) isoxazolidines. Bioorg Med Chem 21: 7929-7937, 2013.
38. Calabrese V, Cornelius C, Trovato A, Cavallaro M, Mancuso C, Di Rienzo L, Condorelli D, De Lorenzo A and Calabrese EJ: The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des 16: 877-883, 2010.
39. Renis M, Calandra L, Scifo C, Tomasello B, Cardile V, Vanella L, Bei R, La Fauci L and Galvano F: Response of cell cycle/stressrelated protein expression and DNA damage upon treatment of CaCo2 cells with anthocyanins. Br J Nutr 100: 27-35, 2008.
40. Alimirah F, Chen J, Basrawala Z, Xin H and Choubey D: DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: Implications for the androgen receptor functions and regulation. FEBS Lett 580: 2294-2300, 2006.
41. Litvinov IV, Antony L, Dalrymple SL, Becker R, Cheng L and Isaacs JT: PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Prostate 66: 1329-1338, 2006.
42. Hagiwara Y, Kasukabe T, Kaneko Y, Niitsu N and Okabe-Kado J: Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells. Int J Hematol 92: 136-143, 2010.
43. Yang Z, Chen H, Huo L, Yang Z, Bai Y, Fan X, Ni B, Fang L, Hu J, Peng J, et al: Epigenetic inactivation and tumor-suppressor behavior of NGFR in human colorectal cancer. Mol Cancer Res 13: 107-119, 2015.
44. Panayiotidis M: Reactive oxygen species (ROS) in multistage carcinogenesis. Cancer Lett 266: 3-5, 2008.
45. Meister A: Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 51: 155-194, 1991.
46. Shaw JP and Chou IN: Elevation of intracellular glutathione content associated with mitogenic stimulation of quiescent fibroblasts. J Cell Physiol 129: 193-198, 1986.